Table 3.

Relationship between anthropometric factors and ERα or PR expression in ovarian tumors

OR (95%CI)
PheterogeneityOR (95%CI)
Pheterogeneity
ERα+ERα−PR+PR−
Height*
    ≤62 inches1.00 (Reference)1.00 (Reference)0.831.00 (Reference)1.00 (Reference)0.08
    >62-≤641.46 (0.63-3.36)1.31 (0.69-2.47)1.14 (0.52-2.48)1.34 (0.76-2.37)
    >64-≤662.24 (0.85-5.90)0.84 (0.33-2.13)0.73 (0.22-2.39)1.63 (0.80-3.30)
    >661.34 (0.50-3.57)1.59 (0.78-3.23)0.59 (0.20-1.79)1.88 (1.01-3.50)
Ptrend0.440.520.400.08
BMI*
    ≤221.00 (Reference)1.00 (Reference)0.511.00 (Reference)1.00 (Reference)0.47
    >221.29 (0.59-2.79)0.95 (0.51-1.75)1.53 (0.65-3.61)0.98 (0.58-1.65)
    >25-≤280.59 (0.23-1.48)0.61 (0.31-1.21)0.78 (0.29-2.07)0.50 (0.27-0.93)
    >280.88 (0.38-2.01)0.61 (0.31-1.20)0.78 (0.29-2.06)0.69 (0.39-1.21)
Ptrend0.470.070.740.08
BMI at 18 y*
    ≤191.11 (0.56-2.22)1.40 (0.77-2.55)0.251.57 (0.74-3.34)1.02 (0.61-1.68)0.24
    >19-≤211.00 (Reference)1.00 (Reference)1.00 (Reference)1.00 (Reference)
    >21-≤230.71 (0.25-1.98)1.49 (0.71-3.11)0.41 (0.09-1.85)1.08 (0.57-2.05)
    >231.04 (0.42-2.61)1.69 (0.82-3.49)1.23 (0.45-3.40)1.37 (0.75-2.51)
Ptrend0.500.340.540.25
Physical activity*
    ≤3 mets/wk1.00 (Reference)1.00 (Reference)0.351.00 (Reference)1.00 (Reference)0.34
    >3-≤210.90 (0.38-2.14)0.84 (0.42-1.70)1.37 (0.49-3.83)0.71 (0.40-1.28)
    >211.81 (0.75-4.36)1.05 (0.48-2.28)1.34 (0.43-4.23)1.20 (0.65-2.22)
Ptrend0.090.650.890.10
  • * Adjusted for age (continuous), duration of OC use (months), number of pregnancies (continuous), and menopausal status at diagnosis (premenopausal/postmenopausal).